We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Tests Diagnose Mental Health Conditions

By Biotechdaily staff writers
Posted on 13 Mar 2007
Blood tests are being developed for panic disorder and other mental health conditions. More...


The findings of University of Iowa (UI; Iowa City, IA, USA) investigators were based on the analysis of genetic information in immature white blood cells and appear online in the March 6, 2007, American Journal of Medical Genetics.

The ability to test for panic disorder is a quantum leap in psychiatry, said the study's lead author, Robert Philibert, M.D., Ph.D., professor of psychiatry in the UI Roy J. and Lucille A. Carver College of Medicine. Panic disorder will no longer be a purely descriptive diagnosis, but, as with cystic fibrosis, Down syndrome, and other conditions, a diagnosis based on genetic information, he said. In addition, the finding could help us better understand the pathways that initiate, promote, and maintain panic disorder.

The team compared gene expression in lymphoblasts (immature white blood cells) culled from 16 participants with panic disorder and 17 participants without the disorder. The study found many genes were more expressed in people with panic disorder than in people without the condition. Similarly, the study found many genes were less expressed in people with panic disorder. There were also sex-related differences.

Overall, people with panic disorder had noticeably different patterns of gene expression than people without the disorder. Although panic disorder is a disease of brain cells, the study used lymphoblasts as stand-ins for the genetic testing because brain cells are not accessible or easily tested.

Panic attacks can involve up to 10 symptoms, including palpitations, shortness of breath, sweating, and a feeling of loss of control or dying--symptoms that are very similar to heart attack symptoms. People with panic disorder often end up in the emergency room for heart tests when in fact they have panic disorder. This is just one of the reasons that it would be helpful to have a blood test for panic disorder, Dr. Philibert said. If we can, it could help us identify systems that interact with the environment and possibly lead the way to new, even non-drug, therapies to prevent illness,

A blood test for commercial use is now being developed by the UI, which raises larger questions about how information revealed by such tests will be used. The issue of patient medical records and how they can potentially be used by employers, insurers, government agencies, and other institutions is a concern, according to Prof. Philibert.



Related Links:
University of Iowa

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.